Logo
x

Search

Subscribe Now

autoimmune

Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs

Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs

  • August 27, 2021
Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

  • May 6, 2021
AbbVie to License I-Mab's Lemzoparlimab (TJC4) for ~$2B

AbbVie to License I-Mab's Lemzoparlimab (TJC4) for ~$2B

  • September 4, 2020
Bio-Thera Signs a License Agreement with Pharmapark for BAT2506 (golimumab- biosimilar)

Bio-Thera Signs a License Agreement with Pharmapark for BAT2506 (golimumab- biosimilar)

  • July 17, 2020
AbbVie Collaborates with Dragonfly Therapeutics to Develop Therapies for Autoimmune and Oncology Indications

AbbVie Collaborates with Dragonfly Therapeutics to Develop Therapies for Autoimmune and Oncology Indications

  • November 21, 2019
Eli Lilly Collaborates with Aduro Biotech for its cGAS-STING Pathway Inhibitor Program to Develop Immunotherapies

Eli Lilly Collaborates with Aduro Biotech for its cGAS-STING Pathway Inhibitor Program to Develop Immunotherapies

  • December 19, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.